Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1

Sponsor
National Institute on Drug Abuse (NIDA) (NIH)
Overall Status
Completed
CT.gov ID
NCT00000352
Collaborator
University of Pennsylvania (Other)
0
1
16
0

Study Details

Study Description

Brief Summary

The purpose of this study is to determine if addition of dextromethorphan to a stable dose of methadone in opioid dependent subjects will significantly affect physical and psychological aspects of opioid tolerance.

Condition or Disease Intervention/Treatment Phase
Phase 2

Study Design

Study Type:
Interventional
Primary Purpose:
Treatment
Official Title:
Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients
Study Start Date :
Dec 1, 1996
Actual Primary Completion Date :
Feb 1, 1998
Actual Study Completion Date :
Apr 1, 1998

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years to 55 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    Please contact site for information.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Pennsylvania Philadelphia Pennsylvania United States 19104 6178

    Sponsors and Collaborators

    • National Institute on Drug Abuse (NIDA)
    • University of Pennsylvania

    Investigators

    • Principal Investigator: Charles O'Brien, M.D., Ph.D., PDVAMC Treatment Research Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00000352
    Other Study ID Numbers:
    • NIDA-3-0012-1
    • Y01-3-0012-1
    First Posted:
    Sep 21, 1999
    Last Update Posted:
    Jan 12, 2017
    Last Verified:
    Aug 1, 1997
    Keywords provided by , ,
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 12, 2017